Loading issues…
- Investing in the future of phage therapyThis week, we're republishing an article Dr. Jon Iredell and Jessica Sacher wrote for GARDP Revive, the Global Antibiotic Research & Development Partnership.

- State of the regulatory affair: Regulation of phage therapy in AustraliaThis week, phage researchers and clinicians from the Westmead Institute and Westmead Hospital brief us on how phage therapy is regulated in Australia, through the lens of their experience treating 14 patients with IV phage therapy.

